ITGAM and plasma cell myeloma: Tumor-infiltrating CD11b+ cells from TCR-Tg mice that reject MOPC315 tumors induce a dose-dependent cytotoxicity against MOPC315 myeloma cells in vitro [(2) and Figure 1A].